334 related articles for article (PubMed ID: 26280536)
1. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
Yuan L; Lv Y; Li H; Gao H; Song S; Zhang Y; Xing G; Kong X; Wang L; Li Y; Zhou T; Gao D; Xiao ZX; Yin Y; Wei W; He F; Zhang L
Nat Cell Biol; 2015 Sep; 17(9):1169-81. PubMed ID: 26280536
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer.
Zhang P; Li C; Li H; Yuan L; Dai H; Peng Z; Deng Z; Chang Z; Cui CP; Zhang L
Cell Death Differ; 2020 Nov; 27(11):3177-3195. PubMed ID: 32483383
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
Pu Q; Lv YR; Dong K; Geng WW; Gao HD
BMC Cancer; 2020 Jun; 20(1):583. PubMed ID: 32571254
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitylation and stabilization of PTEN by USP13.
Zhang J; Zhang P; Wei Y; Piao HL; Wang W; Maddika S; Wang M; Chen D; Sun Y; Hung MC; Chen J; Ma L
Nat Cell Biol; 2013 Dec; 15(12):1486-1494. PubMed ID: 24270891
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.
Du T; Li H; Fan Y; Yuan L; Guo X; Zhu Q; Yao Y; Li X; Liu C; Yu X; Liu Z; Cui CP; Han C; Zhang L
Nat Commun; 2019 Jul; 10(1):2914. PubMed ID: 31266968
[TBL] [Abstract][Full Text] [Related]
6. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2.
Jia F; Li H; Jiao Q; Li C; Fu L; Cui C; Jiang H; Zhang L
Cell Death Dis; 2022 Apr; 13(4):418. PubMed ID: 35490179
[TBL] [Abstract][Full Text] [Related]
8. PTEN stabilizes TOP2A and regulates the DNA decatenation.
Kang X; Song C; Du X; Zhang C; Liu Y; Liang L; He J; Lamb K; Shen WH; Yin Y
Sci Rep; 2015 Dec; 5():17873. PubMed ID: 26657567
[TBL] [Abstract][Full Text] [Related]
9. miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer.
Geng W; Song H; Zhao Q; Dong K; Pu Q; Gao H; Lv Y
Biomed Res Int; 2020; 2020():9512793. PubMed ID: 32775453
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
[TBL] [Abstract][Full Text] [Related]
12. CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy.
Cai J; Li R; Xu X; Zhang L; Lian R; Fang L; Huang Y; Feng X; Liu X; Li X; Zhu X; Zhang H; Wu J; Zeng M; Song E; He Y; Yin Y; Li J; Li M
Nat Cell Biol; 2018 Apr; 20(4):465-478. PubMed ID: 29593330
[TBL] [Abstract][Full Text] [Related]
13. TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer.
McCarroll JA; Gan PP; Erlich RB; Liu M; Dwarte T; Sagnella SS; Akerfeldt MC; Yang L; Parker AL; Chang MH; Shum MS; Byrne FL; Kavallaris M
Cancer Res; 2015 Jan; 75(2):415-25. PubMed ID: 25414139
[TBL] [Abstract][Full Text] [Related]
14. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Christine A; Park MK; Song SJ; Song MS
Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
[TBL] [Abstract][Full Text] [Related]
15. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
16. OTUD3 suppresses the mTORC1 signaling by deubiquitinating KPTN.
Li J; Yang D; Lin Y; Xu W; Zhao SM; Wang C
Front Pharmacol; 2023; 14():1337732. PubMed ID: 38288086
[No Abstract] [Full Text] [Related]
17. Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways.
Cai-McRae X; Zhong H; Karantza V
Oncogene; 2015 Jun; 34(23):2968-77. PubMed ID: 25088198
[TBL] [Abstract][Full Text] [Related]
18. Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity.
Zhang Z; Fang X; Wu X; Ling L; Chu F; Li J; Wang S; Zang J; Zhang B; Ye S; Zhang L; Yang B; Lin S; Huang H; Wang A; Zhou F
Mol Cell; 2020 Jul; 79(2):304-319.e7. PubMed ID: 32679077
[TBL] [Abstract][Full Text] [Related]
19. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
20. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
